© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
Moffitt Cancer Center | Strategic Alliance Partners
Latest from Moffitt Cancer Center
Chief Pharmacy Officer of Moffitt Cancer Center Discusses NCCN Biosimilar Recommendations
April 30, 2021
Video
Kenneth Komorny, PharmD, BCPS, a co-lead on development of National Comprehensive Cancer Network recommendations for biosimilar management, explains some of the positions the NCCN has taken.
Pharmacy Times ® Adds Five Notable New Partners to its Strategic Alliance Partnership Program
April 05, 2021
Article
These nationally recognized health system and oncology leaders will join the esteemed SAP Program.
Obtaining Real-World Disease, Demographic Data on Myelofibrosis
December 11, 2020
Article
Rami Komrokji, MD, clinical director of malignant hematology and department lead clinical investigator at the H. Lee Moffitt Cancer Center and Research Institute speaks about why data are limited in myelofibrosis.
Making Treatment Decisions for Patients with Myelofibrosis
December 10, 2020
Video
Rami Komrokji, MD, clinical director of malignant hematology and department lead clinical investigator at the H. Lee Moffitt Cancer Center and Research Institute speaks about factors in treatment decisions for patients with myelofibrosis.
Triple-Negative Breast Cancer: Improved Outcomes and Providing Patient-Centered Care
March 03, 2020
Article
Melissa B. Armitage, PharmD, BCOP, a clinical pharmacist who works in breast oncology at the Moffitt Cancer Center in Tampa, Florida, discussed this disease's pathophysiology, natural progression, and risk factors.